title: Commentary: preserving confidentiality of interim data.
authors.affiliation: Pfizer Inc., Kalamazoo, MI, USA christy.j.chuang-stein@pfizer.com.
authors.forename: Christy
authors.initials: C
authors.lastname: Chuang-Stein
authors.affiliation: Amgen Inc., Thousand Oaks, CA, USA.
authors.forename: Qi
authors.initials: Q
authors.lastname: Jiang
authors.affiliation: Quintiles, Durham, NC, USA.
authors.forename: Olga
authors.initials: O
authors.lastname: Marchenko
mesh_terms: D026661:Clinical Trials Data Monitoring Committees / Q000458:organization & administration*; D002986:Clinical Trials as Topic / Q000379:methods*; D000068240:Data Anonymization / Q000592:standards*; D005260:Female; D006801:Humans; D008297:Male